Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > NYIT Professor Discovers Next Generation Of DNA And RNA Microarrays

Claude E. Gagna
Claude E. Gagna

Abstract:
A novel invention developed by a scientist from New York Institute of Technology (NYIT) could revolutionize biological and clinical research and may lead to treatments for cancer, AIDS, Alzheimer's, diabetes, and genetic and infectious diseases.

NYIT Professor Discovers Next Generation Of DNA And RNA Microarrays

Old Westbury, NY | Posted on December 1st, 2009

Since the discovery of DNA, biologists have worked to unlock the secrets of the human cell. Scientist Claude E. Gagna, Ph.D., an associate professor at NYIT's School of Health Professions, Behavioral and Life Sciences, discovered how to immobilize intact double-stranded (ds-), multi-stranded or alternative DNA and RNA on one microarray. This immobilization allows scientists to duplicate the environment of a cell, and study, examine and experiment with human, bacterial and viral genes. This invention provides the methodology to analyze more than 150,000 non-denatured genes.

"This patent represents a leap forward from conventional DNA microarrays that use hybridization," says Gagna, a molecular biologist-pathologist who performs research in the structure-function of DNA in normal and diseased cells. "This will help pharmaceutical companies produce new classes of drugs that target genes, with fewer side effects," he adds. "It will lower the cost and increase the speed of drug discovery, saving millions of dollars."

The "Gagna/NYIT Multi-Stranded and Alternative DNA, RNA and Plasmid Microarray," has been patented (#6,936,461) in the United States and is pending in Europe and Asia. Gagna's discovery will help scientists understand how transitions in DNA structure regulate gene expression (B-DNA to Z-DNA), and how DNA-protein, and DNA-drug interactions regulate genes. The breakthrough can aid in genetic screening, clinical diagnosis, forensics, DNA synthesis-sequencing and biodefense.

In the near future, practical applications of the patent will include enabling researchers to directly target and inhibit mutated genes and/or proteins that are responsible for pathologies, making it easier to treat or even cure disease. A discussion of the patent and two new applications -- known as transitional structural chemogenomics and transitional structural chemoproteomics -- was published in the May 2006 issue of Medical Hypotheses (67:1099-1114).

Additionally, Gagna has developed a novel surface that increases the adherence of the DNA to the microarray so that any type of nucleic acid can be anchored. Unlike conventional microarrays, which immobilize single-stranded DNA, scientists will now be able to "secure intact, non-denatured, unaltered ds-DNA, triplex-, quadruplex-, or pentaplex DNA onto the microarray," says Gagna. "With this technology, one day we will have tailor-made molecular medicine for patients."

Invented in 1991, DNA microarrays have become one of the most powerful research tools. Scientists are able to perform thousands of experiments with incredible accuracy and speed. According to MarketResearch.com, by 2009, sales of DNA microarrays are projected to be more than $5.3 billion a year.

Gagna, a resident of Palisades Park, N.J., performs research in his lab at New York College of Osteopathic Medicine of NYIT. He is an adjunct assistant professor at the New Jersey Medical School: Department's of Pathology and Medicine. Gagna earned a Doctor of Philosophy in anatomy and biochemistry from New York University (NYU), Basic Medical Sciences. He completed his postdoctoral work at NYU and at New Jersey Medical School, researching DNA. Gagna received a Master of Science in anatomy from Fairleigh Dickinson University, and a Bachelor of Science in biology from St. Peters College.

For more information about Gagna's patent, please visit www.nyit.edu/dnamicroarrays.

####

About NYIT
NYIT is the college of choice for more than 14,000 students enrolled in more than 100 specialized courses of study leading to undergraduate, graduate and professional degrees in academic areas such as architecture and design; arts and sciences; education and professional services; engineering and technology; extended education; health professions, behavioral and life sciences; management; and osteopathic medicine. As a private, nonprofit, independent institution of higher learning, NYIT embraces an educational philosophy of career-oriented professional education for all qualified students and supports applications-oriented research to benefit the greater global community. Students attend classes at NYIT's campuses in Manhattan and Long Island, as well as online and in a number of programs throughout the world. To date, more than 69,000 alumni have earned degrees at NYIT.

For more information, please click here

Contacts:
Dr. Claude E. Gagna, CChem MRSC, FAIC, ChE
Associate Professor
Director of Biology Laboratories
New York Institute of Technology
Department of Life Sciences
400 Building, Room # 430
Old Westbury, New York 11568-8000

Telephone: (201) 394-5304
Fax: 516.686.3853

Copyright © NYIT

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

'Life Redesigned: The Emergence of Synthetic Biology' Lecture at Brookhaven Lab on Wednesday, April 30: Biomedical Engineer James Collins to Speak for BSA Distinguished Lecture Series April 16th, 2014

ECHA Planning Workshop on Regulatory Challenges in the Risk Assessment of Nanomaterials April 16th, 2014

Nanomedicine

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014

Nanobiotix Appoints Thierry Otin as Head of Manufacturing and Supply April 15th, 2014

PAM-XIAMEN Offers UV LED wafer April 15th, 2014

Announcements

Transparent Conductive Films and Sensors Are Hot Segments in Printed Electronics: Start-ups in these fields show above-average momentum, while companies working on emissive displays such as OLED are fading, Lux Research says April 17th, 2014

Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014

Aerotech X-Y ball-screw stage for economical high performance Planar positioning April 16th, 2014

Energy Research Facility Construction Project at Brookhaven Lab Wins U.S. Energy Secretary's Achievement Award April 16th, 2014

Patents/IP/Tech Transfer/Licensing

Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014

Nanoparticles cause cancer cells to self-destruct April 3rd, 2014

A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014

Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014

Nanobiotechnology

Targeting cancer with a triple threat: MIT chemists design nanoparticles that can deliver three cancer drugs at a time April 15th, 2014

Biologists Develop Nanosensors to Visualize Movements and Distribution of Plant Stress Hormone April 15th, 2014

In latest generation of tiny biosensors, size isn't everything: UCLA researchers overturn conventional wisdom on nanowire-based diagnostic devices April 11th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014

NanoNews-Digest
The latest news from around the world, FREE







  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE